Mitragynine reduces symptoms of alcohol use disorder (and tinnitus) in a self-medication of rodents
Mitragynine reduces symptoms of alcohol use disorder (and tinnitus) in a self-medication of rodents
Kalinichenko, L. S.; Tziridis, K.; Abdoush, N.; Boyer, M.-L.; Emrich, L.; Fejtova, A.; Foerst, N.; Frischknecht, R.; Glotz, A.; Grassl, F.; Hoermann, B.; Kersten, G.-M.; Kienberger, M.; Kirmsse, S.; Perschler, L.; Scheidig, L.; Strotmann, M.; Windhoesel, L.; Radwanska, K.; Heinrich, M. R.; Kornhuber, J.; Singh, D.; Yeou, N. C. J.; Hassan, Z.; Schulze, H.; Mueller, C. P.
AbstractAlcohol use disorder (AUD) is a major psychiatric disease. Available pharmacotherapies show rather modest compliance and efficacy. Tinnitus is a highly aversive hearing problem, that may arise from the same unsolved problems as AUD. Based on a patient report of Kratom, a Southeast Asian plant preparation, efficacy in the self-medication of AUD and tinnitus, we tested the main active Kratom alkaloid, mitragynine, for its therapeutic action in AUD mouse models covering various symptoms of the disease. We found that experimenter administered mitragynine (i.p.) inhibits well-established ongoing alcohol consumption in a social setting when alcohol is permanently available. Mitragynine also inhibits alcohol consumption in a non-social, isolated setting. While mitragynine did not work for prophylaxis during abstinence, it markedly attenuated the relapse to binge drinking with alcohol availability restricted to a limited time. Furthermore, mitragynine reduced alcohol seeking behaviour during its establishment as well as during retrieval from memory. It was also effective to attenuate its re-establishment after extinction. We found significant antidepressive effects of mitragynine, during alcohol withdrawal. To address the compliance problem for pharmacotherapies, we established a test that can monitor this and found that mice after a short training, learned to orally self-administer mitragynine hydrochloride leading to a strong reduction in voluntary alcohol drinking. In parallel, mitragynine reduced tinnitus after a noise trauma in a gerbil model. Together, these findings suggest that mitragynine may be used as a pharmacotherapy for AUD and tinnitus with an expected high compliance rate.